Consumer Discretionary • Catalog/Specialty Distribution
$2.08 ▼ -0.14
(-6.31%)
MKT CAP: $291.6M • VOL: 1.61M
52W L $2 52W H $9
TDUP // SEC EDGAR XBRL STANDARDIZED FINANCIAL STATEMENTS (FA <GO>)
| LINE ITEM (USD / %) | FY 2025
FILED 2025-12-31 | FY 2024
FILED 2024-12-31 | FY 2023
FILED 2023-12-31 |
|---|---|---|---|
| Revenue (Total Sales) | $310.8M | $260.0M | $258.5M |
| YoY Revenue Growth % | +19.5% | +0.6% | — |
| Gross Profit | $246.8M | $207.1M | — |
| Gross Margin % | 79.4% | 79.7% | — |
| Research & Development (R&D) | — | — | — |
| Operating Income (EBIT) | -$21.7M | -$40.6M | -$53.0M |
| Operating Margin % | -7.0% | -15.6% | -20.5% |
| Net Income (GAAP) | -$20.2M | -$77.0M | -$71.2M |
| EBITDA (Normalized) | -$13.4M | -$35.4M | — |
| Diluted EPS ($/sh) | — | — | — |
| Operating Cash Flow (OCF) | — | — | -$22.6M |
| Capital Expenditures (CapEx) | $10.5M | $6.6M | — |
| Free Cash Flow (FCF) | — | — | -$22.6M |
| FCF Margin % | — | — | -8.7% |
| Return on Invested Capital (ROIC %) | -45.0% | -45.0% | — |
| Cash & Short-Term Equivalents | $38.6M | $31.9M | — |
| Total Debt (Short + Long Term) | $14.3M | $18.2M | — |
| Total Stockholders' Equity | $59.2M | $56.3M | — |
NO QUARTERLY 10-Q XBRL STATEMENTS AVAILABLE IN CURRENT CACHE FOR TDUP.